DOCSLIB.ORG

Drug Court Practitioner

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Drug Court Practitioner Drug Court Practitioner February 2016 Fact SheetVol. XI, No. 1 Understanding and Detecting Prescription Drug Misuse and Misuse Disorders By Sandra Lapham, MD, MPH, DFASAM Senior Research Scientist, Behavioral Health Research Center of the Southwest, Pacific Institute for Research and Evaluation his fact sheet is designed for court professionals. It describes prescription T drug misuse and provides information on: • The attributes of the most commonly misused and addictive prescription drugs • The extent and consequences of misuse • Side effects and toxicity • Characteristics of those who are most likely to misuse prescription drugs • Signs and symptoms of misuse • Ways to identify and treat those who may have developed a drug use disorder, including a section on medication-assisted treatment of opioid use disorder • Educational and technical assistance resources on this topic from SAMHSA and other organizations Prescription Drug Misuse drug causes (SAMHSA, 2012). This definition and the Most Commonly covers a wide range of behaviors, from using someone else’s medication to address a Misused Drugs legitimate medical need to misusing prescription The Substance Abuse and Mental Health medications to stay awake, get to sleep, calm Services Administration (SAMHSA) defines down, enhance job or athletic performance, or nonmedical prescription drug misuse as the change one’s mood. use of prescription pain relievers, tranquilizers, People who misuse prescription medications stimulants, sedatives, and other prescription may not understand that, although drugs for drugs in a way other than prescribed, such as treating pain and other medical conditions are for perceived medical need or for the feeling the generally safe when taken as prescribed, they Table 1. Commonly Misused Opioids and Their Applications Generic name Brand name(s) Used to treat OxyContin, Percodan, Percocet, Acute and long-term oxycodone Roxicet, Tylox pain relief Lorcet, Lortab, Vicodin, Acute and long-term/ hydrocodone Vicoprofen chronic pain relief hydromorphone Dilaudid Pain relief Astramorph, Avinza, Duramorph, morphine Post-surgical pain relief Kadian, MS Contin, Roxanol codeine various Pain relief, cough, diarrhea can be dangerous if they are not prescribed for the Opioid Pain Relievers person taking them or not taken as prescribed by Opioids are the most commonly misused their health care provider. prescription drugs. They act on the limbic system A national survey conducted in 2013 shows that (which controls emotions), the brain stem (which prescription drug misuse is a serious public health controls autonomic body functions), and the problem. Approximately 6.5 million (2.5%) of spinal cord (which receives sensory information Americans aged 12 years and older admitted to from the body). As shown in Table 1, medications in this class include hydrocodone (e.g., Vicodin), using prescription drugs nonmedically in the oxycodone (e.g., OxyContin, Percocet), morphine past month (SAMHSA, 2014b). Nonmedical (e.g., Kadian, Avinza), codeine, and related prescription use is especially common among those drugs. Hydrocodone products are the drugs most with chronic pain, teenagers and young adults, and commonly prescribed for a variety of painful those with a history of addiction or other mental conditions, including acute injuries and dental health problems, such as depression and anxiety procedures, as well as chronic conditions, such (Compton & Volkow, 2006). as cancer and arthritis. Morphine is often used before and after surgical procedures to alleviate Prescribed medications that are commonly misused severe pain. Codeine, a milder pain reliever, is in an ongoing or dangerous manner are called often prescribed for less severe pain. In addition psychoactive drugs, as they all affect the brain and to their pain-relieving properties, some of these can have a profound effect on mental states and drugs—codeine and diphenoxylate (Lomotil), processes. The most commonly misused types of for example—can be used to relieve coughs and medications are central nervous system depressants severe diarrhea (National Institute on Drug Abuse (“downers”), which include both opioids and [NIDA], 2014). sedative-hypnotics (tranquilizers and sedatives; Opioid painkillers reduce pain often without Manchikanti, 2006). A third class of drugs—central eliminating its cause. They produce sedation, nervous system stimulants (“uppers”)—are also euphoria, and respiratory depression, and they slow commonly misused. gut function, which frequently leads to constipation. 2 NDCI: The Professional Services Branch of NADCP Understanding and Detecting Prescription Drug Misuse and Misuse Disorders Peak effects generally are reached in 10 minutes if taken Unfortunately, prescription opioid misusers are intravenously, 30 to 45 minutes with an intramuscular increasingly switching to or supplementing with heroin, injection, and 90 minutes by mouth. The absorption of in part due to actions against “doctor shoppers” and “pill toxic doses by mouth may take longer because the retarding mills.” Heroin often is readily available and costs much of gut movement delays drug absorption. less than prescription opioids (Unick, Rosenblum, Mars, & Ciccarone, 2013). Extent and Consequences of Misuse Since 2003, more overdose deaths have involved Side Effects and Toxicity of Opioids prescription opioids than heroin. This epidemic parallels The chief hazard associated with opioid painkillers is the huge increase in the number of prescriptions written respiratory depression (Teater, 2015). These medications for opioid medications over the past decade. Enough is are dangerous because the difference between the amount prescribed annually to give every person in the United needed to feel the effects and a fatal dose is small and States a typical 5 mg dose of Vicodin (hydrocodone and unpredictable. Other drugs—such as alcohol, tranquilizers, acetaminophen) every four hours for three weeks. A Nation barbiturate sedatives (found in sleeping pills and anti- in Pain, a report published by Express Scripts (2014), anxiety medications), and some muscle relaxants that analyzes prescription opioid use in the U.S. from 2009 cause drowsiness (especially carisoprodol [Soma]; Jenkins to 2013. Although the number of Americans using pain et al., 2011)—increase the respiratory depression caused medications long term did not increase over this period, by opioids. So if someone takes their usual dose of opioids, the volume of pain medication sold increased significantly. but adds alcohol or tranquilizers, they may pass out, stop Nearly half of patients who took opioid pain relievers for breathing, and die. more than 30 days in their first year of use continued to Opioids are broken down in the body into harmless use, or misuse, the drugs for three years or more. Almost compounds over time, but the time differs by drug. As a 50% of these patients were taking only short-acting result, mixing extended-release and long-acting opioids can opioids, putting them at higher risk for problematic use. be deadly. And the pain-relieving and euphoria-inducing Two-thirds of patients on these medication mixtures were aspect of opioids may wear off sooner than the respiratory- prescribed the drugs by two or more physicians, and nearly depressant effect. 40% filled their prescriptions at more than one pharmacy. In addition to opioids, nearly one in three patients were Signs of opioid overdose include slowed, obstructed, or taking benzodiazepines, 28% were taking muscle relaxants, stopped breathing; sleepiness progressing to stupor or coma; and 8% were combining all three. Additionally, 27% were weak, floppy muscles; cold and clammy skin; pinpoint taking multiple opioid pain treatments at the same time. pupils; slow heart rate; dangerously low blood pressure; Small southeastern cities had the highest rates of pain and death. Sudden lung injury, uncontrollable seizures, and medication use (Express Scripts, 2014). heart damage can also occur, although less commonly. In response to the epidemic of opioid-related overdose Tolerance is a universal effect of opioids and other drugs deaths, manufacturers have reformulated some of the that leads to a need for increasing dosages to maintain commonly prescribed opioids to deter abuse. Moreover, the drug’s effects. It quickly develops into physiological the public health community has responded to the issue dependence leading to a withdrawal syndrome, unless by educating physicians, implementing prescription the patient gradually tapers down. This process can monitoring programs, modifying drugs to reduce their occur in any opioid user—those who take opioids potential for misuse, and reducing online sources of post-operatively for pain relief as well as persons who prescription opioids (CDC, 2007). The abuse-deterrent misuse them illicitly. Once tolerant and dependent, reformulation of OxyContin, combined with many many chronic users may have a hard time stopping due environmental interventions, has led to reduced availability to the physiological withdrawal symptoms. However, of the most desired non–abuse deterrent formulations. this does not mean such a person has developed an Drug Court Practitioner Fact Sheet 3 Another adverse effect of the chronic use of opioids Common Signs of Opioid is that, when taken for long periods, opioids may actually increase the body’s perception of pain. Overdose This can lead to a feedback loop: need for higher • Slowed, obstructed, or and higher doses, creating more and more risk of stopped
Load more

Recommended publications
  • Supporting the Drug Court Process: What You Need to Know For
    U.S. Department of Justice Office of Justice Programs Bureau of Justice Assistance Supporting the Drug Court Process:What You Need To Know for Effective Decisionmaking MONOGRAPHand Program Evaluation F EBRUARY 2003 SEARCH, The National Consortium for Justice Information and Statistics U.S. Department of Justice Office of Justice Programs 810 Seventh Street NW. Washington, DC 20531 John Ashcroft Attorney General Deborah J. Daniels Assistant Attorney General Richard R. Nedelkoff Director, Bureau of Justice Assistance Office of Justice Programs Home Page www.ojp.usdoj.gov Bureau of Justice Assistance Home Page www.ojp.usdoj.gov/BJA NCJ 197259 This document was prepared by SEARCH,The National Consortium for Justice Information and Statistics, under the Drug Court Training and Technical Assistance Program, under grant number 98–MU–VX–K017, awarded by the Office of Justice Programs, U.S. Department of Justice. The opinions, findings, and conclusions or recommendations expressed in this document are those of the authors and do not necessarily represent the official position or policies of the U.S. Department of Justice. The Bureau of Justice Assistance is a component of the Office of Justice Programs, which also includes the Bureau of Justice Statistics, the National Institute of Justice, the Office of Juvenile Justice and Delinquency Prevention, and the Office for Victims of Crime. Notice n November 2002, the Bureau of Justice Assistance I Bureau of Justice 810 Seventh Street NW. Assistance (BJA) Washington, DC 20531 assumed responsibility Telephone: (202) 616–5001 for administering the Drug Court Grant Fax: (202) 514–6452 Program and the Drug Court Training and E-mail: [email protected] Technical Assistance Program.
    [Show full text]
  • 2008 Idaho Felony Drug Court Outcome Evaluation Report
    An Examination of Idaho’s Felony Drug Courts: Findings and Recommendations FINAL REPORT Shelley Johnson Listwan, Ph.D. Institute for the Study and Prevention of Violence Department of Justice Studies Kent State University James Borowiak, M.A. Department of Justice Studies Kent State University & Edward J. Latessa, Ph.D. Center for Criminal Justice Research Division of Criminal Justice University of Cincinnati August 2008 ______________________________________________ This report was supported through a grant from the Idaho Supreme Court & the Substance Abuse and Mental Health Services Administration (CFDA 93.243). Views expressed are those of the authors and do not necessarily reflect the views of either funding agency. Table of Contents Acknowledgements………………………………………………………………………………3 List of Exhibits…………………………………………………………………………………...4 Section I. Overview………………...………………………………………………………10 Section II. Organizational Issues & Needs ………………………………………………..14 Methodology…………………………………………………………………….14 Sample…………………………………………………………………………...14 Court Descriptions……………………………………………………………...16 Results…………………………………………………………………………...23 Summary………………………………………………………………………...39 Section III. Statewide Outcome Evaluation Results……………………………………….41 Methodology…………………………………………………………………….41 Sample…………………………………………………………………………...41 Measures………………………………………………………………………...45 Analysis………………………………………………………………………….47 Results…………………………………………………………………………...47 Summary………………………………………………………………………..74 Section IV. GRPA Data Summary………………………………………………………….77 Methodology…………………………………………………………………….78
    [Show full text]
  • Western Judicial Circuit Felony Drug Court
    Western Judicial Circuit Felony Drug Court (Athens-Clarke and Oconee Counties) PARTICIPANT HANDBOOK This handbook belongs to: 325 E. Washington Street, Suite 210 Athens, Georgia 30601 (706) 208-7078 (706) 613-3179 (fax) Table of Contents Welcome 3 Overview 4-5 Confidentiality 5 Treatment 5 Program Phases 6-10 Commencement 11 Program Rules 12-14 Program Fees 15 The Drug Court Team 15 Staffings 15 Court Appearances 16 Incentives 17 Sanctions and Treatment Responses 17 Termination 18 Drug/Chemical Testing 19 Prohibited Drugs/Permitted Medications 20-27 Travel/Leave Requests 27 Compliance & Home Visits/Job Checks, Searches 28 Search Requirements 28 Commencement Ceremony 29 Conclusion 29 Important Phone Numbers 30 Community Resources 31 Attachment I: Random Drug Screen Policy Attachment II: Urine Abstinence Testing/Incidental Alcohol Exposure Contract (original signed copy on file with Felony Drug Court) Attachment III: Emergency On-call Telephone Policy Attachment IV: Felony Drug Court Contract 2 Welcome to the Western Judicial Circuit Felony Drug Court! This Handbook was designed to answer your questions and provide specific information about what you must do in order to successfully complete the requirements of the Western Judicial Circuit Felony Drug Court Program. As a participant, you are expected to follow the instructions found in this Handbook, as well as the instructions of the Felony Drug Court Judge, Staff, and Treatment Provider. You will also be expected to comply with the treatment plan developed for you by your Treatment Provider. This handbook is not exhaustive and there is no possible way to make it complete and detailed to answer every question or situation that arises.
    [Show full text]
  • Retrospective Evaluation of Drug Courts in Clark County (Las Vegas) and Multnomah County (Portland)
    The author(s) shown below used Federal funds provided by the U.S. Department of Justice and prepared the following final report: Document Title: From Whether to How Drug Courts Work: Retrospective Evaluation of Drug Courts in Clark County (Las Vegas) and Multnomah County (Portland) Author(s): John S. Goldkamp ; Michael D. White ; Jennifer B. Robinson Document No.: 194124 Date Received: 05/05/2002 Award Number: 98-DC-VX-K001 This report has not been published by the U.S. Department of Justice. To provide better customer service, NCJRS has made this Federally- funded grant final report available electronically in addition to traditional paper copies. Opinions or points of view expressed are those of the author(s) and do not necessarily reflect the official position or policies of the U.S. Department of Justice. R CRIME AND JUSTICE RESEARCHINSTITUTE .---- PROPERTY OF National Criminal Justice Reference Service (NCJRS) Box 6000 Rockville, MD 20849-6000 From Whether to How Drug Courts Work: Retrospective Evaluation of Drug Courts in , Clark County (Las Vegas) and Multnomah County (Portland) Phase II Report,fiorn the National Evaluation of Drug Courts (I) Johi S. Goldkamp Temple University Michael D. White University of North Florida Jennifer B. Robinson University of Ottawa c Approved By: Bate: The researc scribed in this report was supported by grant #98-DC-VX-K001 from the National Institute of Justice, United States Department of Justice. The points of view expressed in the document do not represent the official positions of the National Institute of Justice, the local justice agencies in Multnomah County and Clark County, nor the Federal Government.
    [Show full text]
  • DRUG COURT REVIEW Winter 2019
    DRUG COURT REVIEW Winter 2019 Rural Treatment Court Programs EDITOR IN CHIEF Julie Marie Baldwin, American University ASSOCIATE EDITORS Leola A. Abraham, American University John M. Eassey, American University EDITORIAL SUPPORT Steve Collins, American University Zephi Francis, American University Preeti P. Menon, American University ADVISORY COMMITTEE Jon D. Berg, Substance Abuse and Mental Health Services Administration Jerry Gardner, Tribal Law and Policy Institute Peggy Fulton Hora, Justice Speakers Institute Preeti Menon, American University Carrie F. Mulford, National Institute on Drug Abuse Roger H. Peters, University of South Florida Noreen Plumage, South Dakota State Court Administrators Office Annie Schachar, Center for Court Innovation Faye S. Taxman, George Mason University Gregory D. Torain, US Department of Justice EDITORIAL OFFICE Justice Programs Office American University 4801 Massachusetts Ave NW, Suite 508 Washington, DC 20016 This publication was supported by Grant No. 2016-DC-BX-K008 awarded by the Bureau of Justice Assistance. The Bureau of Justice Assistance is a component of the Department of Justice’s Office of Justice Programs, which also includes the Bureau of Justice Statistics, the National Institute of Justice, the Office of Juvenile Justice and Delinquency Prevention, the Office of Victims of Crime, and the SMART Office. Points of view or opinions in this document are those of the authors and do not necessarily represent the official position or policies of the US Department of Justice. Drug Court Review Winter 2019 3 Introduction to the Issue on Rural 4 - 7 Treatment Court Programs John M. Eassey The Effect of Disproportionate 8 - 25 Sanctioning on Client Noncompliance Jamie C. Vaske Treatment Needs and Gender 26 - 49 Differences Among Clients Entering a Rural Drug Treatment Court with a Co-occurring Disorder Paige M.
    [Show full text]
  • Resource Guide for Drug Court Applicants
    U.S. Department of Justice Office of Justice Programs Bureau of Justice Assistance Drug Court Discretionary Grant Program: FY 2010 Enhancing Adult Drug Court Services, Coordination, and Treatment Solicitation Requirements Resource Guide Table of Contents Introduction ............................................................................................................................................................... 1 About the Requirements Resource Guide .......................................................................................................... 1 Assistance with the Proposal .............................................................................................................................. 1 The Drug Court Movement ................................................................................................................................. 1 Partnership with Treatment ................................................................................................................................. 2 Key Components of Drug Courts........................................................................................................................ 2 General Information................................................................................................................................................... 4 Definitions........................................................................................................................................................... 4 Program Provisions ...........................................................................................................................................
    [Show full text]
  • A Theory of Civil Problem-Solving Courts
    GW Law Faculty Publications & Other Works Faculty Scholarship 2018 A Theory of Civil Problem-Solving Courts Jessica K. Steinberg George Washington University Law School, [email protected] Follow this and additional works at: https://scholarship.law.gwu.edu/faculty_publications Part of the Law Commons Recommended Citation Steinberg, Jessica, A Theory of Civil Problem-Solving Courts (2). 93 N.Y.U. L. Rev. (forthcoming 2018); GWU Law School Public Law Research Paper No. 2018-32; GWU Legal Studies Research Paper No. 2018-32. Available at SSRN: https://ssrn.com/abstract=3219306 This Article is brought to you for free and open access by the Faculty Scholarship at Scholarly Commons. It has been accepted for inclusion in GW Law Faculty Publications & Other Works by an authorized administrator of Scholarly Commons. For more information, please contact [email protected]. Forthcoming, 93 NYU L. Rev. __ (2018) A THEORY OF CIVIL PROBLEM-SOLVING COURTS JESSICA K. STEINBERG* This Article is the first to develop a problem-solving theory for the civil justice system. Drug courts pioneered the problem-solving model in the 1990s to pursue therapeutic goals as an alternative to “assembly line” jail- based sentencing. This Article explores the potential for migration of the drug court framework into the two most commonly adjudicated private law cases: rental housing and consumer debt. Three structural conditions in the civil courts—systemic lack of counsel, high-volume dockets, and corporate capture of the small claims process—routinely position vulnerable classes of individuals on the losing end of litigation. In the aggregate, these conditions have rendered the civil justice system predictably ineffective in combatting recurring social issues such as substandard housing and unscrupulous debt collection.
    [Show full text]
  • Guideline for Drug Courts on Screening and Assessment
    GUIDELINE FOR DRUG COURTS ON SCREENING AND ASSESSMENT Roger H. Peters1 and Elizabeth Peyton2 Prepared for the American University, Justice Programs Office, in association with the U.S. Department of Justice, Office of Justice Programs, Drug Courts Program Office May 1998 1Associate Professor, Department of Mental Health Law and Policy, the Louis de la Parte Florida Mental Health Institute, University of South Florida. 2Executive Director, National TASC — Treatment Accountability for Safer Communities. i ii Acknowledgments The authors express sincere appreciation to the following persons who volunteered their valuable time and expertise to the development of this document: Hon. William G. Meyer Jody Forman Denver Drug Court Project Charlottesville, VA Denver, CO Marc Pearce Hon. Richard S. Gebelein National Association of Drug Delaware Superior Court Court Professionals Wilmington, DE Alexandria, VA Martin O. Conoley Joseph Carloni Santa Barbara County Probation Pathway Treatment Services Santa Barbara, CA Pensacola, FL Ed Brekke Valerie Moore Los Angeles Superior Court IN ACT, Inc. Los Angeles, CA Portland, OR Caroline Cooper The American University Washington, DC iii iv Table of Contents FOREWORD .................................................................................................................. 1 INTRODUCTION .......................................................................................................... 3 What are the differences between screening and assessment? ................................ 3 Goals of screening
    [Show full text]
  • The Multi-Site Adult Drug Court Evaluation: Study Overview and Design, Volume 1
    The author(s) shown below used Federal funds provided by the U.S. Department of Justice and prepared the following final report: Document Title: The Multi-Site Adult Drug Court Evaluation: Study Overview and Design, Volume 1 Author: Shelli B. Rossman, John K. Roman, Janine M. Zweig, Christine H. Lindquist, Michael Rempel, Janeen Buck Willison, P. Mitchell Downey, Kristine Fahrney Document No.: 237109 Date Received: December 2011 Award Number: 2003-DC-BX-1001 This report has not been published by the U.S. Department of Justice. To provide better customer service, NCJRS has made this Federally- funded grant final report available electronically in addition to traditional paper copies. Opinions or points of view expressed are those of the author(s) and do not necessarily reflect the official position or policies of the U.S. Department of Justice. FINAL REPORT: VOLUME Final Version The Multi-Site Adult Drug Court 1 NOVEMBER 2011 Evaluation: Study Overview and Design Shelli B. Rossman, John K. Roman, Janine M. Zweig, Michael Rempel, and Christine H. Lindquist (Editors) Volume 1 Authors: Shelli B. Rossman John K. Roman Janine M. Zweig Christine H. Lindquist Michael Rempel Janeen Buck Willison P. Mitchell Downey Kristine Fahrney URBAN INSTITUTE Justice Policy Center This document is a research report submitted to the U.S. Department of Justice. This report has not been published by the Department. Opinions or points of view expressed are those of the author(s) and do not necessarily reflect the official position or policies of the U.S. Department of Justice. Final Version URBAN INSTITUTE The views expressed are those of the authors, and should Justice Policy Center not be attributed to The Urban Institute, its trustees, or its 2100 M STREET, NW funders.
    [Show full text]
  • Drug Court: a Therapeutic Alternative to Incarceration
    The Review: A Journal of Undergraduate Student Research Volume 5 Article 6 2002 Drug Court: A Therapeutic Alternative to Incarceration Brian Lagenfeld St. John Fisher College, [email protected] Follow this and additional works at: https://fisherpub.sjfc.edu/ur Part of the Social and Behavioral Sciences Commons How has open access to Fisher Digital Publications benefited ou?y Recommended Citation Lagenfeld, Brian. "Drug Court: A Therapeutic Alternative to Incarceration." The Review: A Journal of Undergraduate Student Research 5 (2002): 33-56. Web. [date of access]. <https://fisherpub.sjfc.edu/ur/ vol5/iss1/6>. This document is posted at https://fisherpub.sjfc.edu/ur/vol5/iss1/6 and is brought to you for free and open access by Fisher Digital Publications at St. John Fisher College. For more information, please contact [email protected]. Drug Court: A Therapeutic Alternative to Incarceration Abstract In lieu of an abstract, below is the essay's first paragraph. In the United States, there is a significant drug problem affecting millions directly and countless others indirectly. Drug use and drug-related crime have been on the rise for decades. The government has attempted numerous programs and policies, even declaring a "war on drugs." None of these programs have been effective, as evident in the fact that drug use has continued to rise. Drug use and drug-related crime have caused a number of problems for the United States. The most detrimental are the loss of life and deterioration of the very fundamentals that make up our society. This deterioration includes rising crime rates, the breakup of neighborhoods, and dysfunction in families.
    [Show full text]
  • Queensland Drug and Specialist Courts Review – Final Report Page 1
    Queensland Drug and Specialist Courts Review – Final Report Page 1 THE AUTHORS Emeritus Professor Arie Freiberg AM Faculty of Law Monash University Dr Jason Payne Australian National University Dr Karen Gelb Karen Gelb Consulting Mr Anthony Morgan Australian Institute of Criminology Emeritus Professor Toni Makkai Australian National University DRUG AND SPECIALIST COURTS REVIEW TEAM Victoria Moore Director Julie Webber Principal Policy Officer Leigh Krenske Manager, Research and Evaluation Tara Linnan Project Manager Jamie-Lee Sykes Executive Support Officer Disclaimer The findings and recommendations in this paper reflect the views of the consultants engaged for the Review and do not necessarily reflect the views of the Queensland Government or current government policy. Queensland Drug and Specialist Courts Review – Final Report Page 2 ACKNOWLEDGMENTS We would like to acknowledge and thank the many people who gave their time and participated in the Drug and Specialist Courts Review. The knowledge and experiences that have been shared at workshops, interviews and individual meetings that took place over the course of the Review has been invaluable. The collaboration amongst government agencies has been demonstrated through the commitment and support shown by our inter-agency project team in contributing to the Review. This collaboration has extended to our non-government partners through their participation in the Specialist Court and Court Diversion Program Working Group. We would like to thank our government and non-government partners for providing continual support and guidance throughout the Review. We would also like to acknowledge the support of those magistrates who gave so generously of their time and shared their extensive knowledge and experiences of the former Drug Court and other court programs over the course of the Review.
    [Show full text]
  • Ten Essential Elements of a Mental Health Court
    Improving Responses to People with Mental Illnesses The Essential Elements of a Mental Health Court Improving Responses to People with Mental Illnesses The Essential Elements of a Mental Health Court A report prepared by the Council of State Governments Justice Center Criminal Justice/Mental Health Consensus Project for the Bureau of Justice Assistance Office of Justice Programs U.S. Department of Justice Michael Thompson Dr. Fred Osher Denise Tomasini-Joshi This report was prepared by the Council of State Governments Justice Center, which coordinates the Criminal Justice/Mental Health Consensus Project. It was completed under cooperative agreement 2005-MU-BX-K007 awarded by the Bureau of Justice Assistance (BJA), Office of Justice Programs, U.S. Department of Justice. The opinions and findings in this document do not necessarily represent the official position or policies of the U.S. Department of Justice or the members of the Council of State Governments. While every effort was made to reach consensus and represent advisory group members’ and other reviewers’ recommendations, individual opinions may differ from the statements made in the document. The Bureau of Justice Assistance reserves the right to reproduce, publish, translate, or otherwise use and to authorize others to publish and use all or any part of the copyrighted material contained in this publication. Council of State Governments Justice Center, New York 10005 © 2007 by the Council of State Governments Justice Center All rights reserved. Published 2007. Cover design by
    [Show full text]